The Vita Coco Company, Inc. (COCO) SEC Filings & Earnings Calls
EquiReason read 15 The Vita Coco Company, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-22 — Q3 2026 net sales $244M (+34% YoY), net income $35M ($0.58/diluted share), Non-GAAP Adj. EBITDA $53M. Raises FY2026 guidance: net sales $810-820M, Adj. EBITDA $170-175M..
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
- Market cap
- 3.2B
- P/E TTM
- 28.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 22 Oct, in -2 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
22 Oct 20268-K · 2.02Q3 2026 net sales $244M (+34% YoY), net income $35M ($0.58/diluted share), Non-GAAP Adj. EBITDA $53M. Raises FY2026 guidance: net sales $810-820M, Adj. EBITDA $170-175M.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2026 | $244M | +34% y/y |
| Net income · Q3-2026 | $35M | +46% y/y |
| Non-GAAP Adjusted EBITDA · Q3-2026 | $53M | +66% y/y |
| Net income per diluted share · Q3-2026 | $0.58 | +45% y/y |
| Gross margin · Q3-2026 | 38.0% | |
| Cash and cash equivalents · 2026-09-30 | $152M |
Guidance
FY2026 net sales raised to $810-820M from $790-805M; Non-GAAP Adjusted EBITDA raised to $170-175M; gross margin ~40%
Strong Q3 results and raised full-year guidance driven by robust consumer demand and Copra acquisition.
Risks flagged
Higher domestic logistics costs and Copra acquisition dilution pressure gross margin.
“offset by higher domestic logistics costs, and the dilutive impact of Copra” · word for word
Tariff refunds provided a 240 bps YTD benefit; future tariff changes could reverse this tailwind.
“tariff refunds delivering a 240 basis point benefit to gross margin year-to-date” · word for word
22 Oct 202610-QVita Coco filed quarterly report highlighting tariff refunds and ongoing trade policy risks.open
Figures in the filing · each found in the filing text
| Net sales from International segment · International · Q3-2026 | 17.0% | |
| Tariff refunds received · Q2-2026 | $16M |
Risks flagged
Tariff and trade policy risk
“If the exemptions expire, are scaled back, or otherwise become unavailable, our effective duty rates could increase materially, which could raise our cost of goods sold, compress gross margins, and necessitate price increases or changes to our product, sourcing, or logistics strategies.” · word for word
Litigation risk from labeling and other claims
“We are and have been subject to various labelling, trademark infringement and product quality claims in the ordinary course of our business” · word for word
Public benefit corporation governance risk
“As a public benefit corporation, our focus on a specific public benefit purpose and producing a positive effect for society may negatively impact our financial performance or increase legal risk.”
23 Jul 202610-QThe filing discusses risk factors related to the Copra acquisition and geopolitical disruptions, but no material financial event is reported.open
Risks flagged
Acquisition Integration Risk
“The failure to successfully integrate acquired products or businesses in a timely and cost-effective manner could materially adversely affect our business, prospects, results of operations and financial condition.” · word for word
Operational Model Change Risk
“The Copra acquisition represents a change to our operating model because we have not historically owned or operated any manufacturing facilities.” · word for word
Geopolitical Risk
“The ongoing military conflict involving Iran and related disruption in the Middle East, may adversely affect our business, supply chain, financial condition, and results of operations.” · word for word
23 Jul 20268-K · 2.02Vita Coco raised FY2026 net sales guidance to $790-805M (from $720-735M) and Adjusted EBITDA to $154-161M, driven by strong coconut water growth and tariff refunds.open
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $216M | +28% y/y |
| Gross Profit · Q2-2026 | $105M | |
| Gross Margin · Q2-2026 | 49.0% | |
| Net Income · Q2-2026 | $49M | +113% y/y |
| Net Income per Diluted Share · Q2-2026 | $0.82 | +116% y/y |
| Non-GAAP Adjusted EBITDA · Q2-2026 | $67M | +131% y/y |
| Cash and Cash Equivalents · Q2-2026 | $279M | +42% y/y |
| Inventory · Q2-2026 | $83M | -25% y/y |
| Share Repurchases · H1-2026 | $20M |
Guidance
FY26 net sales raised to $790-805M from $720-735M; FY26 Adjusted EBITDA raised to $154-161M; FY26 gross margin ~40%
Raised full-year guidance driven by strong brand demand, private label trends, and slight gross margin improvement vs prior guidance.
Risks flagged
Gross margin expected to decline in H2 due to cost pressures, despite strong Q2
“While we still expect to see current cost pressures temporarily reduce gross margin for the balance of year” · word for word
Tariff refunds provided a 700 bps benefit in Q2; sustainability uncertain
“tariff refunds delivering a 700 basis point benefit to gross margin in the second quarter” · word for word
22 Jul 20268-K · 1.01, 2.01, 3.02, 7.01Vita Coco acquired Copra Inc. via merger for $175M closing consideration (cash + stock) plus earnout up to $100M. Copra becomes wholly-owned subsidiary. Acquisition of a coconut water brand.acquisitionopen
Figures in the filing · each found in the filing text
| Closing Consideration · 2026-07-22 | $175M | |
| Closing Stock Consideration Shares · 2026-07-22 | 467,071 | |
| Closing Cash Consideration · 2026-07-22 | $140M | |
| Earnout Minimum · FY2028 | $45M | |
| Earnout Maximum · FY2028 | $100M |
Risks flagged
Earnout based on Copra's 2028 gross profit; integration risk and potential dilution from stock consideration.
“Earnout Per Share Consideration will be based on the Gross Profit achieved by Copra during the Calculation Period.” · word for word
Share issuance up to 19.99% of outstanding shares without stockholder approval.
“the Company will not issue to the holders of Copra Capital Stock more than an aggregate of 19.99% of the shares of Vita Coco Common Stock outstanding” · word for word
29 Apr 20268-K · 2.02Net sales $180M (+37% y/y); Vita Coco Coconut Water net sales growth 42; Gross profit $72M (+50% y/y); Guidance: FY2026 net sales raised to $720M-$735M (from $680M-$700M), Adj. EBITDA $132M-$138Mearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $180M | +37% y/y |
| Vita Coco Coconut Water net sales growth · Vita Coco Coconut Water · Q1-2026 | 42.0% | |
| Gross profit · Q1-2026 | $72M | +50% y/y |
| Gross margin · Q1-2026 | 40.0% | |
| Net income · Q1-2026 | $30M | +58% y/y |
| Adjusted EBITDA · Q1-2026 | $39M | +70% y/y |
| Cash and cash equivalents · Q1-2026 | $202M | |
| Inventory · Q1-2026 | $86M | |
| FY2026 gross margin guidance · FY2026 | 38.0% | |
| Share repurchase · Q1-2026 | $12M |
Guidance
FY2026 net sales raised to $720M-$735M (from $680M-$700M), Adj. EBITDA $132M-$138M
Guidance raised on strong Q1 performance; management cites continued brand strength, volume growth, and gross margin improvement.
Risks flagged
Tariff-related costs impacted COGS; higher-cost inventory flowing through partially offset margin gains.
“Tariff-related costs associated with inventory sold during the period compared to the prior year period.” · word for word
SG&A expenses increased 31% due to investments in personnel, sales, marketing, and distributor expenses.
“SG&A expenses were $38 million, compared to $29 million in the prior year period.” · word for word
29 Apr 202610-QNet sales $180M (+37% y/y); Gross profit $72M (+49% y/y); Net income $30M (+61% y/y)open
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $180M | +37% y/y |
| Gross profit · Q1-2026 | $72M | +49% y/y |
| Net income · Q1-2026 | $30M | +61% y/y |
| Diluted earnings per share · Q1-2026 | $0.50 | +61% y/y |
| Cash and cash equivalents · 2026-03-31 | $202M | |
| Americas segment net sales · Americas · Q1-2026 | $148M | +32% y/y |
| International segment net sales · International · Q1-2026 | $32M | +73% y/y |
| Vita Coco Coconut Water net sales · Q1-2026 | $141M | +42% y/y |
| Private Label net sales · Q1-2026 | $33M | +28% y/y |
| Operating cash flow · Q1-2026 | $16M |
Risks flagged
Customer concentration
“Two customers in aggregate represented 46% and 45% of total net sales for the three months ended March 31, 2026 and 2025, respectively.”
Supplier concentration
“Supplier A accounted for 25% of purchases in Q1 2026, up from 14% in Q1 2025.”
Tariff uncertainty
“The Company may be eligible to receive refunds of tariffs previously paid on qualifying imports, but the timing and ultimate resolution remain uncertain.” · word for word
22 Apr 2026DEF 14AProxy statement filed for 2026 annual meeting, disclosing executive compensation, performance metrics, and governance changes including Verlinvest stake reduction and director retirement.open
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $610M | +18% y/y |
| Adjusted EBITDA · FY2025 | $98M | +17% y/y |
| Net income · FY2025 | $71M | +27% y/y |
| Stock price at fiscal year end · FY2025 | $53.01 | +44% y/y |
| Total Shareholder Return (cumulative since 2021) · FY2025 | $474.58 |
Risks flagged
Tariff cost pressure
“The increase in Adjusted EBITDA was primarily driven by strong net sales growth, which was driven by higher volumes and net pricing improvement, offset by cost of goods increases due to tariffs, higher finished good product costs, higher domestic transportation costs, and increased selling, general, and administrative expenses.” · word for word
Key shareholder dilution and governance shift
“During 2025, in connection with block trades, Verlinvest sold an additional 7,760,959 shares of the Company’s outstanding common stock, resulting in a reduction in its shares held from approximately 19.1% to 5.4% of the Company’s outstanding common stock.” · word for word
10 Apr 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
No material risk; retirement is routine and amicable.
“No disagreement or operational impact.”
18 Feb 202610-KRisks named: Intellectual Property Protectionopen
Risks flagged
Intellectual Property Protection
“We may not be able to protect our intellectual property adequately, which may harm the value of our brands.” · word for word
Public Benefit Corporation Governance
“As a public benefit corporation, our focus on a specific public benefit purpose and producing a positive effect for society may negatively impact our financial performance or increase legal risk.”
18 Feb 20268-K · 2.02Net Sales $610M (+18% y/y); Net Income $71M (+27% y/y); Adjusted EBITDA $98M (+17% y/y); Guidance: FY2026 net sales $680-700M (midpoint $690M, +13% YoY); Adjusted EBITDA $122-128M (midpoint $125M, +28% YoY)earningsopen
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $610M | +18% y/y |
| Net Income · FY2025 | $71M | +27% y/y |
| Adjusted EBITDA · FY2025 | $98M | +17% y/y |
| Gross Profit · FY2025 | $223M | +12% y/y |
| Gross Margin · FY2025 | 37.0% | |
| Cash and Cash Equivalents · FY2025 | $197M | +19% y/y |
| Vita Coco Coconut Water Net Sales Growth · Vita Coco Coconut Water · FY2025 | 26.0% |
Guidance
FY2026 net sales $680-700M (midpoint $690M, +13% YoY); Adjusted EBITDA $122-128M (midpoint $125M, +28% YoY)
FY2026 guidance implies strong revenue growth and significant EBITDA margin expansion, driven by continued brand growth and stable cost outlook.
Risks flagged
Tariff costs and higher finished goods costs are pressuring gross margins.
“despite significant tariff costs; Gross margin decreased to 37% ... primarily due to increased finished good product costs and the impact of tariffs”
Private label softness partially offset growth; reliance on key retailers.
“partially offset by a reduction in Private Label sales in certain regions of key retailers” · word for word
17 Nov 20258-K · 7.01Average tariff rate 6open
Figures in the filing · each found in the filing text
| Average tariff rate · 2025-11-17 | 6.0% |
Risks flagged
Continued 40% ad valorem duty on imports from Brazil remains a risk for that sourcing channel.
“40% ad valorem duty applicable to imports from Brazil will continue for the time being.” · word for word
No material impact on 2025 results due to inventory already tariffed; benefit deferred to 2026.
“Company does not expect tariff relief to have a material impact on 2025 financial results.”
29 Oct 202510-QVita Coco reported strong Q3 2025 results with net sales up 37% YoY and net income up 25% YoYearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $182M | +37% y/y |
| Net income · Q3-2025 | $24M | +25% y/y |
| Gross profit · Q3-2025 | $69M | +33% y/y |
| Cash and cash equivalents · 2025-09-30 | $204M | |
| Operating cash flow · 9M-2025 | $51M | +42% y/y |
Risks flagged
Customer concentration
“Two customers in aggregate represented 45% of total net sales for the nine months ended September 30, 2025”
Supplier concentration
“Supplier A accounted for 16% of purchases; Supplier B 13%; Supplier C 11%”
29 Oct 20258-K · 2.02Net sales $182M (+37% y/y); Vita Coco Coconut Water net sales growth 42; Gross profit $69M (+33% y/y); Guidance: Net sales guidance raised to $580-$595M; Adjusted EBITDA guidance raised to $90-$95Mearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $182M | +37% y/y |
| Vita Coco Coconut Water net sales growth · Vita Coco Coconut Water · Q3-2025 | 42.0% | |
| Gross profit · Q3-2025 | $69M | +33% y/y |
| Gross margin · Q3-2025 | 38.0% | |
| Net income · Q3-2025 | $24M | +26% y/y |
| Diluted EPS · Q3-2025 | $0.40 | +25% y/y |
| Non-GAAP Adjusted EBITDA · Q3-2025 | $32M | +39% y/y |
| Cash and cash equivalents · Q3-2025 | $204M |
Guidance
Net sales guidance raised to $580-$595M; Adjusted EBITDA guidance raised to $90-$95M
Company raises full-year guidance on strong momentum; gross margin expected to be ~36% due to tariff and cost headwinds
Risks flagged
Tariff cost pressure impacting gross margin; gross margin expected to be ~36% for full year
“Gross margin expected to be approximately 36% with increased finished goods costs versus 2024, and the impact of current tariffs” · word for word
SG&A expenses increasing high-single digits, outpacing revenue growth in some periods
“SG&A expenses expected to increase high-single digits versus 2024” · word for word
The Vita Coco Company, Inc. — questions
- What did The Vita Coco Company, Inc. file recently?
- 15 SEC filings in the last 12 months. Latest: 8-K on 2026-10-22 — Q3 2026 net sales $244M (+34% YoY), net income $35M ($0.58/diluted share), Non-GAAP Adj. EBITDA $53M. Raises FY2026 guidance: net sales $810-820M, Adj. EBITDA $170-175M.
Every figure on this page comes from The Vita Coco Company, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.